Evidence map›Paper›PMID 33525414›Full record

ArticleMolecules (Basel, Switzerland)2021

Carmen Jiménez-Espinoza, Francisco Marcano Serrano, José Luis González-Mora

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Carmen Jiménez-EspinozaLaboratory Neurochemistry & Neuroimages, Department of Basic Medical Sciences, Faculty of Health Sciences, Physiology Section, University of La Laguna, 38200 Tenerife, Spain.ORCID 0000-0002-6254-2396
Francisco Marcano SerranoLaboratory Neurochemistry & Neuroimages, Department of Basic Medical Sciences, Faculty of Health Sciences, Physiology Section, University of La Laguna, 38200 Tenerife, Spain.
José Luis González-MoraLaboratory Neurochemistry & Neuroimages, Department of Basic Medical Sciences, Faculty of Health Sciences, Physiology Section, University of La Laguna, 38200 Tenerife, Spain.
Universidad de La Laguna · ES

Funding

Ministerio de Ciencia e Innovación PTA2011-4995-I, TIN2011-28146
6 · The paper itself

Abstract

As brain functional resonance magnetic studies show an aberrant trajectory of neurodevelopment, it is reasonable to predict that the degree of neurochemical abnormalities indexed by magnetic resonance spectroscopy (

Indexed as

AdultAspartic AcidAstrocytesAutism Spectrum DisorderBiomarkersCerebral CortexDipeptidesFemaleGlutamic AcidHumansMaleNeuronsOligodendrogliaProton Magnetic Resonance SpectroscopyYoung AdultAspartic AcidBiomarkersDipeptidesGlutamic Acidisospaglumic acidautism spectrum disorderbiomarkersbrain metabolismcingulated corticesN-Acetyl-aspartyl-glutamateresonance magnetic spectroscopy

Identifiers

PMID33525414
PMCPMC7866086
OpenAlexW3123707412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.